Sessa Capital IM, L.P.'s Form 4 filing
Provention Bio, Inc. (PRVB) · filed Apr 18, 2023
- Accession no.
- 0001062993-23-009310
- Filed
- Apr 18, 2023, 8:57 PM ET
- Trade date
- Apr 14, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $53.3M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sessa Capital IM, L.P.CIK 0001595849 | 10% Owner |
| Sessa Capital (Master), L.P.CIK 0001618360 | 10% Owner |
| Sessa Capital GP, LLCCIK 0001618699 | 10% Owner |
| Sessa Capital IM GP, LLCCIK 0001618700 | 10% Owner |
| Petry JohnCIK 0001618702 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2023 | Common Stock | XIn-the-money exerciseAcquired | +8,879,023 | $6.00 | +$53,274,138 | 17,758,046 | Direct | |
| Apr 14, 2023 | Common Stock | SSaleDisposed | −2,190,549 | $24.32F3 | −$53,274,151.68 | 15,567,497 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2023 | Common Stock | XIn-the-money exerciseDisposed | −8,879,023 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Calculated based on the closing price or last reported sale price of a share of Common Stock for the business day immediately prior to the date of the warrant exercise.
Referenced by the price of 1 transaction in Table I.